OTCMKTS:MSSTF Mindset Pharma (MSSTF) Stock Price, News & Analysis $0.54 0.00 (0.00%) As of 10/27/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Mindset Pharma Stock (OTCMKTS:MSSTF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Mindset Pharma alerts:Sign Up Key Stats Today's Range$0.54▼$0.5450-Day Range$0.54▼$0.5452-Week Range$0.16▼$0.56VolumeN/AAverage Volume33,313 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Mindset Pharma is a clinical‐stage biopharmaceutical company dedicated to the discovery and development of novel psychedelic‐inspired small molecules for the treatment of neurological and psychiatric disorders. By leveraging advanced medicinal chemistry and structure‐based drug design, the company seeks to optimize naturally occurring psychoactive compounds for improved safety, selectivity and pharmacokinetic properties. Mindset’s preclinical and early clinical assets are focused on conditions such as post‐traumatic stress disorder, major depressive disorder and cluster headache. The company’s proprietary chemistry platform enables the systematic generation and evaluation of psilocybin analogs, mescaline derivatives and other psychoactive scaffolds. Integrating computational modeling, in vitro pharmacology and in vivo studies, Mindset refines lead candidates to enhance blood–brain barrier penetration, metabolic stability and receptor binding profiles. This iterative approach aims to deliver differentiated therapeutics that offer once‐daily dosing, reduced psychoactivity and an improved side‐effect profile compared to native psychedelics. Founded in 2018 and headquartered in Montreal, Canada, Mindset Pharma conducts its research and development activities both domestically and through collaborative partnerships in North America. The company is guided by an experienced leadership team with deep expertise in neuropsychopharmacology, drug discovery and regulatory strategy. Supported by alliances with academic institutions and industry stakeholders, Mindset is advancing its pipeline toward clinical proof-of-concept studies, with the goal of bringing new treatment options to patients with unmet needs in central nervous system disorders.AI Generated. May Contain Errors. Read More Receive MSSTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Mindset Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address MSSTF Stock News HeadlinesMadrigal Pharmaceuticals: Looking To Finally Establish A Position Around The Q3 EarningsOctober 28, 2024 | seekingalpha.comCrispr Therapeutics: Poised For A Major TurnaroundOctober 28, 2024 | seekingalpha.comThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.August 23 at 2:00 AM | Weiss Ratings (Ad)Why Indian students should choose Ireland as their study-abroad destination: Expert answers your questionsOctober 17, 2024 | msn.comNews snapshot: LithiumBank, Minto Metals, Versus Systems, Mindset Pharma, PyroGenesis, Soma Gold UPDATE...October 16, 2024 | proactiveinvestors.com.auThese three market leading stocks can plunge if Kamala Harris wins US electionsOctober 10, 2024 | msn.comTranscript: The Futurist: What’s Next with AI?October 3, 2024 | washingtonpost.comCelestica: Institutional Investors Are Buying, So Am ISeptember 27, 2024 | seekingalpha.comSee More Headlines MSSTF Stock Analysis - Frequently Asked Questions How have MSSTF shares performed this year? Mindset Pharma's stock was trading at $0.5381 at the beginning of the year. Since then, MSSTF shares have increased by 0.0% and is now trading at $0.5381. How do I buy shares of Mindset Pharma? Shares of MSSTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:MSSTF CIKN/A Webwww.mindsetpharma.com PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:MSSTF) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mindset Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mindset Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.